SCHEMBL25001753

SCHEMBL25001753

CN/C=C(\C=N)c1cc(Nc2ncc(Br)c(Nc3ccc4nccnc4c3P(C)(C)=O)n2)c(OC)cc1N1CCN(C(C)C)CC1

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25002718 0.95 EGFR (0.57) EGFR
SCHEMBL25002444 0.91 EGFR (0.55) EGFR
SCHEMBL25001833 0.90 EGFR (0.54) EGFR
SCHEMBL25001825 0.90 EGFR (0.75) EGFR
SCHEMBL25002710 0.90 EGFR (0.56) EGFR
SCHEMBL25001822 0.89 EGFR (0.60) EGFR
SCHEMBL25002999 0.89 EGFR (0.68) EGFR
SCHEMBL25002048 0.88 EGFR (0.67) EGFR
SCHEMBL24565230 0.87 EGFR (0.70) EGFR
SCHEMBL25002091 0.87 EGFR (0.56) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129996-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-08 — — EP disclosed
Send feedback